Sarepta (SRPT) valued at unbelievable $11 BILLION and has still only one drug on Market .
--------
If former Chairman can repeat that what they did on SRPT then our Antisense has more than 10000% upside potential and even that would be wayyy lower than current valuation of SRPT . Its sad that this pure Goldmine is not listed on Nasdaq then this one would be valued north of $500 Million right now .
https://unauthorised investment advice/health/could-antisense-be-the-next-multi-billion-duchenne-muscular-dystrophy-biotech/
“I joined the board of Sarepta in 2007. We were in a very similar circumstance as Antisense,” he told *.
“We had a low market cap, we had low cash balance, we were fighting to get to the point where we could prove out our drug. Now look at what’s changed in the last 10 years. That’s what we’re trying to achieve at Antisense.”
DMD Phase 2 Results in Q4 = Potential 5000% Gem, page-44
-
- There are more pages in this discussion • 259 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $94.66M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 10.5¢ | $35.58K | 335.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 375558 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 41673 | 2 |
View Market Depth
| Last trade - 11.01am 18/09/2024 (20 minute delay) ? |
| PER (ASX) Chart |